ArticleMedicine2025
Acute hepatitis E virus infection as a trigger for postinfectious IgA nephropathy: A rare case report.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
rationaleIgA nephropathy (IgAN) is most often idiopathic but may occur following infections. While associations with hepatitis B and C are recognized, its link with acute hepatitis E virus () infection is rarely described and remains poorly understood. PATIENT CONCERNS: A 37-year-old male presented with fever, sore throat, vomiting, generalized weakness, and dark-colored urine for 2 days. DIAGNOSES: Laboratory evaluation showed markedly elevated liver enzymes, hyperbilirubinemia, and acute kidney injury. Hepatitis E IgM was positive. Renal biopsy demonstrated postinfectious IgA nephropathy with mesangial hypercellularity and moderate acute tubular injury.
interventionsThe patient received supportive therapy, including intravenous fluids, hemodialysis, plasma exchange, and corticosteroid treatment with intravenous methylprednisolone followed by an oral prednisolone taper. OUTCOMES: Renal function progressively improved. By 3 months, serum creatinine decreased from 703 µmol/L at admission to 135 µmol/L, with resolution of symptoms and no recurrence of hematuria or renal impairment. LESSONS: This case suggests that acute HEV infection may act as a trigger for postinfectious IgA nephropathy. Clinicians should consider IgAN in patients with HEV who develop renal dysfunction, as timely recognition and management can substantially improve outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.